Do neurocognitive functions in cannabis induced psychosis groups differ from schizophrenia with cannabis use? A controlled cross-sectional study

References

• Aggarwal M, Banerjee A, Singh SM, Mattoo S, Basu D. 2012. Substance-induced psychotic disorders: 13-year data from a de-addiction centre and their clinical implications. Asian J Psychiatr. 5(3):220–224.
   PubMedGoogle Scholar
• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (TX): American Psychiatric Publishing.
   Google Scholar
• Andreasen NC, Carpenter WT, Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. 2005. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 162(3):441–449.
   PubMed Web of Science ®Google Scholar
• Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jorgensen P. 2005. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. Br J Psychiatry. 187:510–515.
   PubMed Web of Science ®Google Scholar
• Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. 2002. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 325(7374):1212–1213.
   PubMed Web of Science ®Google Scholar
• Bang M, Kim KR, Song YY, Baek S, Lee E, An SK. 2015. Neurocognitive impairments in individuals at ultra-high risk for psychosis: who will really convert? Aust N Z J Psychiatry. 49(5):462–470.
   PubMed Web of Science ®Google Scholar
• Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, Pappadopulos E, Willson DF, Alvir JM, Woerner MG, et al. 2000. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry. 157(4):549–559.
   PubMed Web of Science ®Google Scholar
• Blair C. 2006. How similar are fluid cognition and general intelligence? A developmental neuroscience perspective on fluid cognition as an aspect of human cognitive ability. Behav Brain Sci. 29(2):109.
   PubMed Web of Science ®Google Scholar
• Bolt LK, Amminger GP, Farhall J, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, et al. 2019. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: findings from the NEURAPRO randomized clinical trial. Schizophr Res. 206:67–74.
   PubMed Web of Science ®Google Scholar
• Brandt J, Ralph HB, Benedict RH. 2001. Hopkins verbal learning test- revised. Odessa: Psychological Assessment Resources, Inc.
   Google Scholar
• Dufouil C, Alpérovitch A, Tzourio C. 2003. Influence of education on the relationship between white matter lesions and cognition. Neurology. 60(5):831–836.
   PubMed Web of Science ®Google Scholar
• Fusar-Poli P, Deste G, Smieskova R, Barlati S, Yung AR, Howes O, Stieglitz RD, Vita A, McGuire P, Borgwardt S. 2012. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch Gen Psychiatry. 69(6):562–571.
   PubMed Web of Science ®Google Scholar
• Grant I, Gonzalez R, Carey CL, Natarajan L, Wolfson T. 2003. Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc. 9(5):679–689.
   PubMed Web of Science ®Google Scholar
• Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J. 1996. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry. 153:1195–1201.
   PubMed Web of Science ®Google Scholar
• Heaton RK. 2003. Wisconsin Card Sorting test (WCST) computer version-2 for windows. Research ed. Odessa: Psychological Assessment Resources, Inc.
   Google Scholar
• Joyal CC, Hallé P, Lapierre D, Hodgins S. 2003. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia. Schizophr Res. 63(3):297–299.
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13(2):261–276.
   PubMed Web of Science ®Google Scholar
• Kendler KS, Ohlsson H, Sundquist J, Sundquist K. 2019. Prediction of onset of substance-induced psychotic disorder and its progression to schizophrenia in a Swedish national sample. Am J Psychiatry. 176(9):711–719.
   PubMed Web of Science ®Google Scholar
• Kløve H. 1963. Clinical neuropsychology. Med Clin N Am. 47(6):1647–1658.
   PubMed Web of Science ®Google Scholar
• Lezak MD. 1995. Neuropsychological assessment. 3rd ed. New York (NY): Oxford University Press.
   Google Scholar
• Malone DT, Hill MN, Rubino T. 2010. Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. Br J Pharmacol. 160(3):511–522.
   PubMed Web of Science ®Google Scholar
• Maynard TM, Sikich L, Lieberman JA, LaMantia AS. 2001. Neural development, cell-cell signaling, and the “two-hit” hypothesis of schizophrenia. Schizophr Bull. 27(3):457–476.
   PubMed Web of Science ®Google Scholar
• Niendam TA, Bearden CE, Rosso IM, Sanchez LE, Hadley T, Nuechterlein KH, Cannon TD. 2003. A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. Am J Psychiatry. 160(11):2060–2062.
   PubMed Web of Science ®Google Scholar
• Oldfield RC. 1971. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 9(1):97–113.
   PubMed Web of Science ®Google Scholar
• Olney JW, Farber NB. 1995. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 52(12):998–1007.
   PubMed Web of Science ®Google Scholar
• Pershad D, Verma SK. 1988. Translation and adaptation of WAIS-R Verbal scale in Hindi: concept and assessment of Intelligence. New Delhi: National Psychological Corporation.
   Google Scholar
• Raven JC. 1938. Progressive matrices, Sets A, B, C, D, E. H.K. London: Lewis & Co., Ltd.
   Google Scholar
• Reitan RM, Wolfson D. 1985. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Tucson (AZ): Neuropsychology Press.
   Google Scholar
• Rodríguez-Sánchez JM, Ayesa-Arriola R, Mata I, Moreno-Calle T, Perez-Iglesias R, González-Blanch C, Periañez JA, Vazquez-Barquero JL, Crespo-Facorro B. 2010. Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophr Res. 124(1–3):142–151.
   PubMed Web of Science ®Google Scholar
• Rund BR. 1998. A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophr Bull. 24(3):425–435.
   PubMed Web of Science ®Google Scholar
• Ruxton GD, Beauchamp G. 2008. Time for some a priori thinking about post hoc testing. Behav Ecol. 19(3):690–693.
   Web of Science ®Google Scholar
• Schnakenberg Martin AM, Bonfils KA, Davis BJ, Smith EA, Schuder K, Lysaker PH. 2016. Compared to high and low cannabis use, moderate use is associated with fewer cognitive deficits in psychosis. Schizophr Res Cogn. 6:15–21.
   PubMedGoogle Scholar
• Scott JC, Slomiak ST, Jones JD, Rosen AFG, Moore TM, Gur RC. 2018. Association of cannabis with cognitive functioning in adolescents and young adults: a systematic review and meta-analysis. JAMAPsychiatry. 75(6):585–595.
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Dunbar GC. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiat. 59:22–33.
   PubMed Web of Science ®Google Scholar
• Sørensen HJ, Mortensen EL, Parnas J, Mednick SA. 2006. Premorbid neurocognitive functioning in schizophrenia spectrum disorder. Schizophr Bull. 32(3):578–583.
   PubMed Web of Science ®Google Scholar
• SPSS Inc. 2007. Statistical package for social sciences (SPSS) for Windows, Version 16.0. Chicago (IL): SPSS Inc.
   Google Scholar
• Van Os J, Bak M, Hanssen M, Bijl RV, De Graaf R, Verdoux H. 2002. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol. 156(4):319–327.
   PubMed Web of Science ®Google Scholar
• Wechsler D. 1997. Wechsler memory scale (WMS-III). San Antonio (TX): Psychological Corporation.
   Google Scholar
• World Health Organization 2019. The international classification of diseases for mortality and morbidity statistics. 11th ed. Geneva: World Health Organization.
   Google Scholar
• Yücel M, Bora E, Lubman DI, Solowij N, Brewer WJ, Cotton SM, Conus P, Takagi MJ, Fornito A, Wood SJ. 2012. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull. 38(2):316–330.
   PubMed Web of Science ®Google Scholar
• Zalesky A, Solowij N, Yücel M, Lubman DI, Takagi M, Harding IH, Lorenzetti V, Wang R, Searle K, Pantelis C. 2012. Effect of long-term cannabis use on axonal fibre connectivity. Brain. 135(Pt 7):2245–2255.
   PubMed Web of Science ®Google Scholar
• Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. 2002. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Br Med J. 325(7374):1199–1199.
   PubMed Web of Science ®Google Scholar